Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Minor software revision from v3.3.3 to v3.3.4; no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:20:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added a new Locations section with Massachusetts sites to clarify where the study is conducted. - Removed the HHS Vulnerability Disclosure link and updated revision metadata from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-30T16:20:24.000Z thumbnail image
  4. Check
    56 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify PubMed sourcing, and the revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:21.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The government funding/NIH operating status banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:04:16.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    No significant additions or deletions detected between the two page versions; any differences appear minor or cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:58:29.000Z thumbnail image
  7. Check
    106 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating status guidance, and a new version tag v3.2.0. - Removed the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T22:47:23.000Z thumbnail image

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.